BCK Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

BCK Capital Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,000	Closed	-$883K	–	102
2023 Q2	$883K	Buy	+19,000	New	+$657K	0.67%	26

BCK Capital Management's DICE Position: Q3 2023 in Review

BCK Capital Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 19,000 shares — an estimated $883K sold.

BCK Capital Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $883K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

BCK Capital Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
BCK Capital Management sold 19,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $883K.
BCK Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
BCK Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $883K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on BCK Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.